Page last updated: 2024-09-03

jolkinolide b and Laryngeal Neoplasms

jolkinolide b has been researched along with Laryngeal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dong, L; Kang, S; Liu, D; Liu, F; Wang, J; Yang, X1

Other Studies

1 other study(ies) available for jolkinolide b and Laryngeal Neoplasms

ArticleYear
Jolkinolide B attenuates laryngeal cancer cell growth and induces apoptosis via PTEN/PI3K/Akt signaling pathway.
    In vitro cellular & developmental biology. Animal, 2021, Volume: 57, Issue:8

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromones; Diterpenes; Flow Cytometry; Fluorescent Antibody Technique; Humans; Hylobatidae; Insulin-Like Growth Factor I; Laryngeal Neoplasms; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Real-Time Polymerase Chain Reaction; Signal Transduction

2021